Orphan Drugs: In Development
DEVELOPMENT DISEASE DRUG NAME SPONSOR FDA OFFICIAL DESIGNATION STATUS Spasticity, Neuralgon Mericon Industries treatment of intractable spasticity Phase II Intractable L-baclofen (Peoria, IL) associated with spinal cord injury (continued) or multiple sclerosis Thrombocythemia Agrelin~ Roberts Pharmaceutical treatment of essential Phase III anagrelide (Eatontown, NJ) thrombocythemia (ET) Thrombo- Arvin~ Knoll Pharmaceuticals antithrombotic for patients with Phase II cytopenia ancrod (Whippany, NJ) heparin-induced thrombocytopenia or thrombosis who require immediate and continued anticoagulation iloprost Berlex treatment of heparin-associated application submitted (Wayne, NJ) thrombocytopenia Tissue/Organ Nizoral Pharmedic for use with cyclosporine A to Phase I Transplantation ketaconazole (Wheeling, IL) diminish the nephrotoxicity induced by cyclosporine in organ transplantation Trigeminal Neuralgon Gerhard Fromm, M.D. treatment of trigeminal neuralgia Phase II Neuralgia L-baclofen (Pittsburgh, PA) Tuberculosis aconiazide Lincoln Diagnostics treatment of tuberculosis Phase II (Decatur, IL) Rifater~ Marion Merrell Dow short-course treatment of Phase III rifampin, isoniazid, (Kansas City, MO) tuberculosis pyrazinamide Turner's ethinyl estradiol - Gynex Pharmaceuticals treatment of Turner's syndrome Phase III S Syndrome (Vernon Hills, IL) Humatrope~ Eli Lilly treatment of short stature associated in clinical trials somatropin of (Indianapolis, IN) with Turner's syndrome recombinant DNA origin Norditropin~ Novo-Nordisk treatment of short stature associated Phase III somatropin (Princeton, NJ) with Turner's syndrome Nutropin Genentech treatment of short stature associated Phase III somatropin for (S. San Francisco, CA) with Turner's syndrome injection OxandrinTM Gynex Pharmaceuticals treatment of short stature associated Phase III oxandrolene (Vernon Hills, IL) with Turner's syndrome Uremic 24, 25 dihydroxy- TAG Pharmaceuticals/ treatment of uremic osteodystrophy Phase III Osteodystrophy cholecalciferol Lemmon Company (Sellersville, PA) Ventricular bethanidine sulfate Medco Research treatment of primary ventricular Phase III Fibrillation (Los Angeles, CA) fibrillation bethanidine sulfate Medco Research prevention of recurrence of primary Phase II/III (Los Angeles, CA) ventricular fibrillation Ventricular Betapace~ Bristol-Myers Squibb prevention of life-threatening application submitted Tachyarrhythmias d,l-sotalol HCL (New York, NY) ventricular tachyarrhythmias Betapace~ Bristol-Myers Squibb treatment of life-threatening application submitted d,l-sotalol HCL (New York, NY) ventricular tachyarrhythmias Von Willebrand's DDAVP Rhone-Poulenc Rorer (see Hemophilia) Disease desmopressin acetate (Collegeville, PA) NovoSevenTM Novo-Nordisk A/S (See Hemophilia) factor VIIa (Copenhagen, Denmark) (recombinant DNA origin) Vulvar VulvanTM Star Pharmaceuticals treatment of vulvar dystrophies Phase III completed Dystrophies testosterone (Pompano Beach, FL) propionate ointment 2% Wilson's Disease zinc acetate Lemmon Company treatment of Wilson's disease Phase III (Sellersville, PA) Xerostomia Salagen~ Tablets MGI PHARMA treatment of xerostomia induced by application submitted pilocarpine HCL (Minneapolis, MN) radiation therapy for head and neck cancer
About this Item
- Title
- Orphan Drugs: In Development
- Author
- Pharmaceutical Research and Manufacturers of America
- Canvas
- Page 14
- Publication
- Pharmaceutical Manufacturers Association.
- 1992
- Subject terms
- reports
- Series/Folder Title
- Marketplace > Press releases, reports, and newsletters
- Item type:
- reports
Technical Details
- Collection
- Jon Cohen AIDS Research Collection
- Link to this Item
-
https://name.umdl.umich.edu/5571095.0504.010
- Link to this scan
-
https://quod.lib.umich.edu/c/cohenaids/5571095.0504.010/14
Rights and Permissions
The University of Michigan Library provides access to these materials for educational and research purposes, with permission from their copyright holder(s). If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission.
Related Links
IIIF
- Manifest
-
https://quod.lib.umich.edu/cgi/t/text/api/manifest/cohenaids:5571095.0504.010
Cite this Item
- Full citation
-
"Orphan Drugs: In Development." In the digital collection Jon Cohen AIDS Research Collection. https://name.umdl.umich.edu/5571095.0504.010. University of Michigan Library Digital Collections. Accessed June 10, 2025.